Hollings Annual Report 2023 FINAL - Flipbook - Page 9
recognition
center
accreditations
Cancer Center
A Cancer Center Designated by the
National Cancer Institute
Hollings leaders offer expertise to Cancer
Moonshot groups
Marvella E. Ford, Ph.D., and Benjamin Toll,
Ph.D., were invited to offer their expertise to the
Cancer Moonshot. The Moonshot was lauched
in 2016 and reignited in 2022 by President Joe
Biden with new goals. The program’s vision is to
cut the cancer death rate by half within 25 years
and improve the lives of cancer survivors. To
achieve this, the Moonshot mobilizes researchers,
clinicians, patients and advocates.
Ford was invited to serve on the External Scientific
Panel for the Cancer Moonshot Biobank, which
collects donated blood and tissue samples from
cancer patients. Toll is part of the Cancer Moonshot
Smoking Cessation Forum, which seeks to provide
guidance for cancer centers to build tobacco
cessation programs for cancer patients.
Additional distinctions:
•
Raymond N. DuBois, M.D.,
Ph.D., director of MUSC
Hollings Cancer Center, was
inducted as a fellow into the
Royal College of Physicians
(RCP). The RCP was
established in 1518 by a royal
charter from King Henry VIII.
Fellows are senior clinicians
who have demonstrated
achievement and impact on
the field of medicine. The
RCP’s mission is to “drive
improvements in health and
healthcare through advocacy,
education and research.”
Celebrating 30 Years
•
Evan Graboyes, M.D., director
of the Survivorship and Cancer
Outcomes Research initiative
at Hollings, was named vice
chair of NRG Oncology’s
health disparities committee.
NRG Oncology is a
cooperative group conducting
multi-institutional, federally
funded cancer clinical trials.
Graboyes will help incorporate
health disparities research in
NRG Oncology trials and
expand the committee’s health
disparities educational and
mentoring efforts.
7
